David Sancho (@SanchoLab) - Twitter Profili | Zamantika Mersobahis Locabet

Sabitlenmiş Tweet

David Sancho@SanchoLab·10 Şub

Excessive #inflammation? We uncover @immunity that #IFN‑I via #ISG15 in #macrophages lowers #mitochondrial membrane potential, boosts #efferocytosis, and self‑limits #ISG amplification: a built‑in brake that promotes resolution. Open-access: sciencedirect.com/science/articl…

English

2

22

82

10.5K

David Sancho retweetledi

Annalaura M. PhD@annalaura_mstrn·9h

Thrilled to receive the EAS Young Investigator Award 2026 for our work on imidazole propionate in atherosclerosis. Huge thanks to @SanchoLab, @Teriyaky_852, and all collaborators. Inspired to keep advancing research on #gut #microbiota‑derived #metabolites & #Aterosclerosis!

CNIC@CNIC_CARDIO

🏆 @CNIC_CARDIO researcher @annalaura_mstrn, a member of the Immunobiology laboratory led by @sancholab, has received the EAS Young Investigator Award 2026 (Basic Science) from the @society_eas. 💡 Her paper, “Imidazole propionate is a driver and therapeutic target in atherosclerosis”, published in @Nature, identifies how a metabolite derived from the #microbiota contributes to the development of #atherosclerosis and proposes new therapeutic targets. The Clinical Science Award has also been awarded to Nick Nurmohamed (@amsterdamumc). Congratulations! 🎉 #CNIC #Research #WomenandScience #WomenatCNIC #Immunobiology

English

0

1

3

312

David Sancho retweetledi

CNIC@CNIC_CARDIO·1d

🏆 @CNIC_CARDIO researcher @annalaura_mstrn, a member of the Immunobiology laboratory led by @sancholab, has received the EAS Young Investigator Award 2026 (Basic Science) from the @society_eas. 💡 Her paper, “Imidazole propionate is a driver and therapeutic target in atherosclerosis”, published in @Nature, identifies how a metabolite derived from the #microbiota contributes to the development of #atherosclerosis and proposes new therapeutic targets. The Clinical Science Award has also been awarded to Nick Nurmohamed (@amsterdamumc). Congratulations! 🎉 #CNIC #Research #WomenandScience #WomenatCNIC #Immunobiology

English

2

5

18

1.1K

David Sancho retweetledi

CNIC@CNIC_CARDIO·6 Mar

The interview is conducted on the occasion of the #CNICSeminars ‘Metabolic regulators of apoptotic cell clearance’. 👤 Organized by @SanchoLab

English

1

212

David Sancho retweetledi

CNIC@CNIC_CARDIO·6 Mar

#InterviewsCNIC 🎙️ @JustinPerryPhD 🗣️ ‘In science, we are wrong all the time’. Research in the Perry Lab at @MSKCancerCenter broadly focuses on understanding the mechanisms underlying the “healthy” clearance of dying cells, known as efferocytosis. 🫀🔬 📰 Find out more in this #interview for #CNICPulse: cnic.es/en/noticias/ju… #Science #CardiovascularResearch #CVD

English

1

334

David Sancho retweetledi

Samarth Hegde@samhegde2006·26 Şub

Always a mind-blowing talk from @SanchoLab who showed, alongside data on macs, that cIII inhibition in cDC1 has functional consequence on anti-tumor immunity > mitochondrial ETC disruption impact on histone demethylase and alter PU.1 pioneer activity. Everything linked !

English

1

2

350

David Sancho retweetledi

Marisol Soengas@msmelanoma·18 Şub

When high level science and technology meet and offer hope for future patients with triple negative breast cancer. From the ⁦@BioNTech_Group⁩ and collaborators Individualized mRNA vaccines evoke durable T cell immunity in adjuvant TNBC | Nature nature.com/articles/s4158…

English

0

4

13

932

David Sancho retweetledi

Brenner Lab@Brenner_Lab·18 Şub

🚨 Only 10 days left! Join us at EIMN2026 | 2nd European Immunometabolism Conference 📍 Luxembourg | 🗓 June 10–12, 2026 👉 Register & submit your abstract by March 1 👉 3 days of cutting-edge immunometabolism, real discussion & strong networking 🔗 eimn2026.lu/en/

English

0

4

8

578

David Sancho retweetledi

SEInmunología@SEinmunologia·16 Şub

📣Continuamos con la XLIII sesión de nuestro #ImmunologyClub el Jueves 19 de Febrero a las 15h. En esta ocasión contamos con AnnaLaura Mastrangelo e Iñaki Robles. 🗣️Hablarán de su reciente trabajo “Imidazole propionate is a driver and therapeutic target in aterosclerosis”📰

Español

0

8

13

1.4K

David Sancho retweetledi

Ivan Zanoni@Lo_Zanzi·15 Şub

#WeekendRead! #InterferonFriendOrFoe? @JeffDowney11 @SwirskiLab &co show @ImmunityCP that upon severe flu lung infection, IAV is transported to the heart by dendritic cells, where it infects cardiomyocytes to drive IFN-I, causing cardiac dysfunction! doi.org/10.1016/j.immu…

English

0

17

45

5K

David Sancho@SanchoLab·14 Şub

@Lo_Zanzi @ImmunityCP Thanks for sharing, Ivan! 🫂

English

0

1

187

David Sancho retweetledi

Ivan Zanoni@Lo_Zanzi·14 Şub

#WeekendRead! #InterferonPower! Dunphy @SanchoLab &co show @ImmunityCP that in #macrophages, #STING drives IFN-I, ISG15 & ISGlatyion of mitochondrial proteins, boosting #efferocytosis & driving #epigenetic reprogramming to favor inflammation resolution! sciencedirect.com/science/articl…

English

2

16

67

5.1K

David Sancho@SanchoLab·14 Şub

@CNIC_CARDIO

QAM

0

190

David Sancho@SanchoLab·14 Şub

#PhD in immunometabolism on fatty acid oxidation in #macrophage function. MSCA-doctoral network unimedizin-mainz.de/unlimited-msca… For our DC8 position apply in parallel in 2 sites: 1. unimedizin-mainz.de/unlimited-msca… 2. cnic.es/en/convocatori… (DC8: NOT resident >12m in Spain in last 3 years)

English

1

13

30

2.6K

David Sancho@SanchoLab·14 Şub

Great opportunity for a #PhD on how lipid metabolism regulates immune cell function in diseases such as cancer and autoimmunity. Train in immunology, bioIT, & metabolism. Apply in parallel in two sites: 1. UNLIMITED: unimedizin-mainz.de/unlimited-msca… 2. Local partner site that you choose.

English

0

13

39

2.6K

David Sancho retweetledi

CNIC@CNIC_CARDIO·13 Şub

Save the date! 🔔 #CNICseminars🗣️ @JustinPerryPhD from @ThePerryLab at @MSKCancerCenter ➡️ “Metabolic regulators of apoptotic cell clearance”. 👨‍🔬 Chair: @SanchoLab 📅 February 16, 12 pm 📍CNIC Auditorium, Madrid More info: cnic.es/es/actualidad/… #SOMMa #CardiovascularResearch #CVD

English

0

4

678

David Sancho@SanchoLab·11 Şub

@ImmunoFever Very interesting hypothesis, Michal! thanks for your comment!🫂

English

0

2

172

David Sancho retweetledi

Michal Tal, PhD@ImmunoFever·11 Şub

This explains so much! See how antiviral signaling directly interferes with mitochondrial function, meant as an inflammation off ramp but I'm sure this is part of the catastrophic mitochondrial dysfunction in chronic illness with sustained elevated IFN levels.

David Sancho@SanchoLab

Excessive #inflammation? We uncover @immunity that #IFN‑I via #ISG15 in #macrophages lowers #mitochondrial membrane potential, boosts #efferocytosis, and self‑limits #ISG amplification: a built‑in brake that promotes resolution. Open-access: sciencedirect.com/science/articl…

English

6

18

88

6.3K

David Sancho retweetledi

Idoyaga Lab@Idoyaga_Lab·11 Şub

Are you obsessed with #DendriticCells? Curious? Running into them in your experiments? Then ✳️ #DC2026 is your meeting! Registration & abstracts are OPEN. Top-tier speakers and more to come. ⭐️ Come for the science. Stay for the community. @MaxKrummel @ZunigaLab

UCSF Bakar ImmunoX Initiative@immunox

Registration is now open and an all-in roster of immunologists anchor the premiere biyearly Dendritic cell meeting. dc2026sandiego.com/invited-speake… Sunny (blue state) San Diego. Come for the great science and collaborative community.

English

0

5

12

2.5K

David Sancho@SanchoLab·11 Şub

@IIC_UMU_IMIB @ImmunoFever Thanks, Víctor!

Español

0

1